Bulk Scale Formulation of Therapeutic Doses of Clinical Grade Ready-to-Use <sup>177</sup> Lu-DOTA-TATE: The Intricate Radiochemistry AspectsAnupam Mathur, S.S. Sachdev, V. MANE DESHMUKH PRASHANT et al.|Cancer Biotherapy and Radiopharmaceuticals|2017Cited by 8
One decade of 'Bench-to-Bedside' peptide receptor radionuclide therapy with indigenous [<sup>177</sup>Lu]Lu-DOTATATE obtained through 'Direct' neutron activation route: lessons learnt including practice evolution in an Indian setting.Sandip Basu, Sharmila Banerjee, Sudipta Chakraborty et al.|PubMed|2020Cited by 7
Radiation and radioisotopes for human healthcare applicationsSharmila Banerjee, R. A. Badwe, Vedang Murthy et al.|Current Science|2022Cited by 5